Trademark: 85557129
Word
ALACRITA
Status
Registered
Status Code
800
Status Date
Friday, June 30, 2023
Serial Number
85557129
Registration Number
4256669
Registration Date
Tuesday, December 11, 2012
Mark Type
4000
Filing Date
Thursday, March 1, 2012
Published for Opposition
Tuesday, September 25, 2012

Trademark Owner History
ALACRITA HOLDINGS LIMITED -
Alacrita LLP - Original Registrant

Classifications
36 Financial advice for companies in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; arranging funding, namely, providing financing services, investment consultancy; information, consultancy and advice relating to any of the aforesaid services
35 Business and market research; business analysis, business planning, business management and business strategy, namely, strategic planning services, strategy development services and business consultancy in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; business advice regarding the development and commercialization of products in the fields of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and healthcare industries; recruitment and personnel services, namely, personnel placement; tax services, namely, tax consultation and accountancy services; advertising and promotional services; arranging business networking meeting opportunities for businesses to meet potential investors and to promote their products; information, consultancy and advice relating to any of the aforesaid services; management of clinical trials for drugs, vaccines, diagnostic reagents, small molecules, medical devices, namely, providing information management services, providing clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and application for drug approval, or providing independent reviews of clinical trials for business purposes; preparation of reports on clinical trials of drugs, vaccines, diagnostic reagents, small molecules, and medical devices, namely, providing information, management and compilation of computerized databases in the field of clinical trials for business purposes; preparing technical business or financial reports on clinical trials of drugs, vaccines, diagnostic reagents, small molecules, medical devices, preparation of reports on clinical trials of drugs, vaccines, diagnostic reagents, small molecules, and medical devices
42 Research in the field of pharmaceuticals, biotechnology, life sciences, medical products, medical devices and scientific research in the field of healthcare industries; clinical research, namely, managing clinical trials for others, providing medical and scientific research information in the field of clinical trials; testing of pharmaceuticals, diagnostic reagents or medical products; conducting of clinical trials for others for drugs, vaccines, diagnostic reagents, small molecules, medical devices; providing scientific information, namely, preparation of reports on clinical trials of drugs, vaccines, diagnostics, small molecules, cellular therapies, medical devices, and research reagents; scientific research, namely, writing of medical research and scientific research-related documents and preparing reports on medical research and scientific research-related documents; testing the safety of pharmaceuticals, vaccines, diagnostic reagents, small molecules, cellular therapies, and medical devices, and information, consultancy and advice relating to any of the aforesaid services; consultancy, advice and information in the field of development of drugs, vaccines, diagnostic reagents, small molecules, and medical devices
Color is not claimed as a feature of the mark.

Trademark Events
Jul 1, 2023
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Jun 30, 2023
Registered And Renewed (First Renewal - 10 Yrs)
Jun 30, 2023
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jun 30, 2023
Case Assigned To Post Registration Paralegal
Dec 6, 2022
Teas Section 8 & 9 Received
Dec 11, 2021
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Nov 15, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 15, 2020
Teas Change Of Correspondence Received
Nov 15, 2020
Teas Change Of Domestic Representatives Address
Nov 15, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 15, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 15, 2020
Teas Change Of Owner Address Received
Dec 8, 2018
Notice Of Acceptance Of Sec. 8 - E-Mailed
Dec 8, 2018
Registered - Sec. 8 (6-Yr) Accepted
Dec 8, 2018
Case Assigned To Post Registration Paralegal
Dec 3, 2018
Teas Section 8 Received
Dec 11, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 24, 2017
Automatic Update Of Assignment Of Ownership
Mar 19, 2014
Teas Change Of Correspondence Received
Dec 11, 2012
Registered-Principal Register
Sep 25, 2012
Official Gazette Publication Confirmation E-Mailed
Sep 25, 2012
Published For Opposition
Sep 5, 2012
Notification Of Notice Of Publication E-Mailed
Aug 22, 2012
Law Office Publication Review Completed
Aug 22, 2012
Approved For Pub - Principal Register
Aug 22, 2012
Examiner's Amendment Entered
Aug 22, 2012
Notification Of Examiners Amendment E-Mailed
Aug 22, 2012
Examiners Amendment E-Mailed
Aug 22, 2012
Examiners Amendment -Written
Aug 16, 2012
Amendment From Applicant Entered
Aug 16, 2012
Correspondence Received In Law Office
Aug 14, 2012
Fax Received
Jul 31, 2012
Notification Of Final Refusal Emailed
Jul 31, 2012
Final Refusal E-Mailed
Jul 31, 2012
Final Refusal Written
Jul 12, 2012
Amendment From Applicant Entered
Jul 12, 2012
Correspondence Received In Law Office
Jul 12, 2012
Assigned To Lie
Jul 2, 2012
Fax Received
Jun 19, 2012
Notification Of Non-Final Action E-Mailed
Jun 19, 2012
Non-Final Action E-Mailed
Jun 19, 2012
Non-Final Action Written
Jun 12, 2012
Assigned To Examiner
Mar 8, 2012
New Application Office Supplied Data Entered
Mar 5, 2012
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24